| Clinical data | |
|---|---|
| Other names |
|
| Routes of administration | Oral |
| Drug class | |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Eliminationhalf-life | 1.8–8.6 hours[2] |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.007.050 |
| Chemical and physical data | |
| Formula | C9H13NO |
| Molar mass | 151.21 g·mol−1 |
| 3D model (JSmol) | |
| Solubility in water | 20 mg/mL (20 °C) |
| |
| |
| | |
D-norpseudoephedrine, also known ascathine and(+)-norpseudoephedrine, is apsychoactive drug. It is astimulant.